Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

381 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Transarterial Chemoembolization with Anthracyclines-Loaded Polyethylene Glycol Drug Eluting Microspheres for the Treatment of Hepatocellular Carcinoma: A Pooled Multicentric Analysis of Survival in 580 Patients.
Veloso Gomes F, de Baère T, Verset G, Coimbra É, Tovar-Felice G, Malagari K, Bruix J. Veloso Gomes F, et al. Among authors: bruix j. Cardiovasc Intervent Radiol. 2023 Apr;46(4):436-446. doi: 10.1007/s00270-023-03362-9. Epub 2023 Feb 10. Cardiovasc Intervent Radiol. 2023. PMID: 36764953 Free PMC article.
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.
European Association for Study of Liver; European Organisation for Research and Treatment of Cancer. European Association for Study of Liver, et al. Eur J Cancer. 2012 Mar;48(5):599-641. doi: 10.1016/j.ejca.2011.12.021. Eur J Cancer. 2012. PMID: 22424278 Free article. No abstract available.
Treatment of Hepatocellular Carcinoma.
Díaz-González Á, Reig M, Bruix J. Díaz-González Á, et al. Among authors: bruix j. Dig Dis. 2016;34(5):597-602. doi: 10.1159/000445275. Epub 2016 Jun 22. Dig Dis. 2016. PMID: 27332893 Review.
Polyethylene Glycol Drug-Eluting Embolic Microspheres Loaded with Doxorubicin for the Treatment of Hepatocellular Carcinoma: Feasibility, Safety, and Pharmacokinetic Study.
Malagari K, Denys A, Burrel M, Reig M, Brunet M, Duran R, Kiakidis T, Moschouris H, Sanduzzi-Zamparelli M, Bruix J. Malagari K, et al. Among authors: bruix j. J Vasc Interv Radiol. 2022 Jul;33(7):752-761. doi: 10.1016/j.jvir.2021.11.019. Epub 2022 Mar 26. J Vasc Interv Radiol. 2022. PMID: 35351630
Hepatocellular carcinoma.
Llovet JM, Burroughs A, Bruix J. Llovet JM, et al. Among authors: bruix j. Lancet. 2003 Dec 6;362(9399):1907-17. doi: 10.1016/S0140-6736(03)14964-1. Lancet. 2003. PMID: 14667750 Review.
Chemoembolization for hepatocellular carcinoma.
Bruix J, Sala M, Llovet JM. Bruix J, et al. Gastroenterology. 2004 Nov;127(5 Suppl 1):S179-88. doi: 10.1053/j.gastro.2004.09.032. Gastroenterology. 2004. PMID: 15508083 Review.
Treatment of hepatocellular carcinoma.
Forner A, Hessheimer AJ, Isabel Real M, Bruix J. Forner A, et al. Among authors: bruix j. Crit Rev Oncol Hematol. 2006 Nov;60(2):89-98. doi: 10.1016/j.critrevonc.2006.06.001. Epub 2006 Jul 24. Crit Rev Oncol Hematol. 2006. PMID: 16860993 Review.
381 results